Patients with chronic lymphocytic leukaemia are at an increased risk of developing severe coronavirus disease (COVID-19). Although rollout of the novel vaccines against the disease may offer hope to ending the pandemic, their efficacy in patients with chronic lymphocytic leukaemia may be significantly lower compared to the general population.
COVID-19 vaccine, chronic lymphocytic leukemia, mRNA vaccine, coronavirus, pandemic
Access all of the content
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!